FindTrial
Sign In

A Clinical Trial To Study The Effects Of Two Drugs, Dexamethasone And Dexmedetomidine Given As a Regional Anaesthesia In Patients Undergoing Shoulder Surgeries

Comparative Study Of Dexamethasone And Dexmedteomidine As Adjuvants To 0.5 Percent Ropivacine In Combined Interscalene And Supraclavicular Block For Patients Undergoing Shoulder Surgeries: A Prospective Randomized Controlled Double Blind Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098423
Enrollment
48
Registered
2025-12-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M241- Other articular cartilage disorders Health Condition 2: M621- Other rupture of muscle (nontraumatic) Health Condition 3: M620- Separation of muscle (nontraumatic) Health Condition 4: M668- Spontaneous rupture of other tendons Health Condition 5: M669- Spontaneous rupture of unspecifiedtendon Health Condition 6: M256- Stiffness of joint, not elsewhereclassified

Interventions

Intervention1: Ropivacaine With Dexmedetomidine: 28ml Of 0.5% Ropivacaine And 2ml Of Dexmedetomidine (1 microgram/Kg) Administered In Combined Interscalene And Supraclavicular block Control Interventi

Sponsors

Manipal Hospital Whitefield
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective shoulder surgery under combined interscalene and supraclavicular block 2. Patients classified under American Society of Anesthesiologists physical status I or II classification

Exclusion criteria

Exclusion criteria: 1. Patients who choose not to participate in the study. 2. Patients who are allergic to local anaesthetics 3. Pregnant or lactating individuals 4. Patients with bleeding diathesis or those using anticoagulants 5. Patients with history of serious neurological or psychiatric disorders 6. Patients on systemic corticosteroids for at least two weeks or more within six months of surgery 7. Patients with a history of long term opioid or other analgesic consumption 8. Presence Infection or lesion at the site of block

Design outcomes

Primary

MeasureTime frame
TO COMPARE THE DURATION OF SENSORY BLOCKADE BETWEEN THE DEXAMETHASONE AND DEXMEDETOMIDINE GROUP OF PATIENTSTimepoint: Baseline, 4 hours, 8 hours, 12 hours, 16 hours, 20 hours, 24 hours—

Secondary

MeasureTime frame
Duration Of Motor BloackadeTimepoint: 24 Hours;Postoperative Analgesic RequirementsTimepoint: 24 Hours;Postperative Pain scoresTimepoint: 24 hours;Patient Satisfaction ScoreTimepoint: 24 Hours;Incidence Of Adverse EffectsTimepoint: 24 Hours—

Countries

India

Contacts

Public ContactBHARATHI HOSDURG

MANIPAL HOSPITAL WHITEFIELD

mirnuuu@gmail.com9842015338

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026